On June 9, Ma Xusheng, secretary of the party group and director of the Anhui Provincial Food and Drug Administration, and his party visited Fuqing Medical, accompanied by Zhu Dehong, director of the Medical Device Production Supervision Division, Xiong Yongheng, deputy director of the Licensing and Registration Office, and Cheng Xiaobing, deputy director of the Evaluation and Inspection Center. research. Professor Qiu Bensheng, Chief Scientist of Fuqing Medical, General Manager Zhou Yufu, Deputy General Manager Zhang Qing, and Deputy General Manager Du Huiyu warmly received the visit.

Zhou Yufu introduced the company's product matrix to the research team

The research team visited CLIMBER148 superconducting magnetic resonance, cardiovascular interventional magnetic resonance, discrete intraoperative magnetic resonance, PET/MR research and development workshop, 7T ultra-high field scientific research magnetic resonance, liquid helium-free superconducting magnet research and development and production Workshop and mobile MRI examination vehicle. During the visit, Ma Xusheng asked Zhou Yufu many times to gain an in-depth understanding of the core product technology, imaging methods and theories, etc., and fully affirmed Fuqing Medical's research and development strength and the speed of transformation of scientific and technological achievements.

The research team stopped to watch the actual operation video of the product

The research team visited the mobile magnetic resonance diagnosis and treatment vehicle

After the visit, the two sides held a symposium on the declaration and registration of medical devices and the development of the high-end medical equipment industry in the future.

At the symposium, Qiu Bensheng first reported to the research team the technical problems that the company has or is currently overcoming, and then made a brief statement on Fuqing Medical’s exploration to solve primary medical care—the combination of hardware equipment physical examination and software remote diagnosis, Finally, he put forward suggestions and suggestions to the research team on speeding up the medical device approval process and building a new medical system.

The research team stated that Fuqing Medical relies on the platform of the University of Science and Technology, has outstanding talent advantages, and a variety of products under research are at the international leading level. It is hoped that enterprises will continue to expand investment in research and development, step up innovative product layout, make proper use of capital, build sound marketing channels, and create a good brand image. Regarding the declaration of the three types of medical devices, enterprises can directly connect with the Yangtze River Delta Sub-Center for Medical Device Technical Review and Inspection, actively feedback problems and their own demands, and promote high-quality products to enter the market earlier.

Ma Xusheng said that Fuqing Medical has a wide variety of innovative products and diversified application scenarios, and the development of the enterprise has been closely watched by various government departments. The Provincial Food and Drug Administration has always been committed to promoting innovative medical devices from research and development to clinical practice, and ultimately benefiting the people. In the follow-up, the Food and Drug Administration will continue to optimize the process, provide services and professional guidance in the approval and registration, and strictly control product quality to actively promote the high-speed and high-quality development of the medical equipment industry in Anhui Province.

The person in charge of the company reports the company profile to the research team

Anhui Provincial Food and Drug Administration research group photo

Fuqing Medical is a national high-tech enterprise that is empowered by the scientific and technological achievements of the University of Science and Technology of China, and specializes in the research and development, production, sales, operation and maintenance of high-end medical imaging diagnosis and treatment equipment. Incubated by the Institute of Advanced Technology of the University of Science and Technology of China, the company is an entity operating platform for the industrialization of scientific research achievements of the Engineering Laboratory of Magnetic Resonance Guided Precision Therapy in Anhui Province and the Precision Medical Equipment Technology Research Center of the Institute of Advanced Technology of the University of Science and Technology of China.

The company cooperates with the Biomedical Engineering Center of the University of Science and Technology of China, the Precision Medical Equipment Technology Research Center of the Advanced Research Institute of the University of Science and Technology of China, the First Affiliated Hospital of the University of Science and Technology of China and other institutions to actively explore the four-in-one transformation model of scientific research achievements of "production, learning, research and medicine". Deeply promote the six-in-one industrial development model of "politics, production, learning, research, medicine, and finance" to provide systematic solutions for the precise treatment of major human diseases.